CHC LABS INC.
|
PROSTATE SPECIFIC ANTIGEN (84153) |
|
|
185 |
Malignant neoplasm of prostate |
|
188.5 |
Malignant neoplasm of bladder neck |
|
196.5 |
Secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb |
|
196.6 |
Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes |
|
196.8 |
Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites |
|
198.5 |
Secondary Malignant neoplasm of bone and bone marrow |
|
198.82 |
Secondary Malignant neoplasm of genital organs |
|
233.4 |
Carcinoma in situ of prostate |
|
236.5 |
Neoplasm of uncertain behavior of prostate |
|
239.5 |
Neoplasms of unspecified nature of other genitourinary organs |
|
596.0 |
Bladder neck obstruction |
|
599.60 |
Urinary obstruction, unspecified |
|
599.69 |
Urinary obstruction, not elsewhere classified |
|
599.7 |
Hematuria |
|
600.01 |
Benign prostate hypertrophy with urinary obstruction |
|
601.9 |
Prostatitis unspecified |
|
602.9 |
Unspecified disorder of prostate |
|
788.20 |
Retention of urine unspecified |
|
788.21 |
Incomplete bladder emptying |
|
788.30 |
Urinary incontinence unspecified |
|
788.41 |
Urinary frequency |
|
788.43 |
Nocturia |
|
788.62 |
Slowing of urinary stream |
|
790.93 |
Elevated prostate specific antigen (PSA) |
|
793.6-793.7 |
Nonspecific abnormal findings on radiological and other examination of abdominal area including retroperitoneum |
|
794.9 |
Nonspecific abnormal results of other specified function study |
|
V10.46 |
Personal history of malignant neoplasm of prostate |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|